Home › Graft-Versus-Host Disease › Illinois › Chicago
Graft-Versus-Host Disease clinical trials in Chicago, IL
3 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- The University of Chicago Medical Center (UCMC), Chicago
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
RecruitingPhase 2
- University of Chicago, Chicago
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- University of Illinois Medical Center - Hematology & Oncology, Chicago
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Columbus, OH6 studies
- Atlanta, GA5 studies
- Washington, DC5 studies
- St. Louis, MO4 studies
- Portland, OR4 studies
- Baldwin Park, CA4 studies
- Tampa, FL4 studies
- Detroit, MI4 studies
- Pittsburgh, PA4 studies
- Miami, FL4 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.